Adding lapatinib to capecitabine cuts progression of advanced breast cancer
|
Thanks Rhonda for this article which may help me to convince one onc to add Tykerb to Xeloda in the case of an elderly lady in my family.
The published results of this trial add more support for the benefits of Tykerb which were presented in June 2006 at ASCO. Since the added side effects of Tykerb appear to be minor(rash & diarrhia) & overall survival may be extended (according to comments in the aricle), there seems to be no reason not to add Tykerb. |
All times are GMT -7. The time now is 04:18 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021